JPRN-UMIN000033159已完成2 期
Phase2 Clinical Trial of Hepatocyte Growth Factor Gene Therapy for Primary Lymphedema - Phase2 Clinical Trial for Primary Lymphedema
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1, stage 3 by ISL classification 2, aplasia or hyperplasia 3, another hereditary 4, malignancy 5, cellulitis at the time of registration 6, received the operation within 90 days 7, severe disease of liver, kidney, heart, or blood 8, alcohol dependence 9, registration of another clinical trials within 90 days 10, the pregnant 11, received the treatment of another gene therapy 12, unfitness patient
研究者
相似试验
进行中（未招募）
1 期
Pilot trial of recombinant human growth hormone for remyelination in multiple sclerosis - rhGH in MSMedDRA version: 9.1Level: LLTClassification code 10063399Term: Relapsing-remitting multiple sclerosisMedDRA version: 9.1Level: LLTClassification code 10063400Term: Secondary progressive multiple sclerosisMultiple SclerosisEUCTR2006-006465-16-DEniversity of Leipzig
撤回
2 期
Efficacy and Safety of VM202 in Painful Diabetic Peripheral Neuropathy -The HOPES TrialPainful Diabetic NeuropathyNCT04087941Brigham and Women's Hospital50
Unknown
3 期
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1)IschemiaUlcersPeripheral Vascular DiseaseArterial Occlusive DiseaseNCT04275323Beijing Northland Biotech. Co., Ltd.300
已完成
2 期
Hepatocyte Growth Factor to Improve Functioning in PADPeripheral Artery DiseaseNCT03363165Northwestern University39
进行中（未招募）
不适用
Treatment With Recombinant Human Growth Hormone (Genotonorm) in Children With Short Stature Secondary to a Long Term Corticoid Therapy. A Study of Efficacy and SafetyJuvenile idiopathic arthritis (JIA) and nephrotic syndrome (NeS)EUCTR2014-004104-30-Outside-EU/EEAPharmacia & Upjohn S.A.30